Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57,709,383
-
Total 13F shares
-
50,639,622
-
Share change
-
-2,223,918
-
Total reported value
-
$1,391,452,892
-
Put/Call ratio
-
69%
-
Price per share
-
$27.48
-
Number of holders
-
236
-
Value change
-
-$78,862,126
-
Number of buys
-
105
-
Number of sells
-
136
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q3 2019
As of 30 Sep 2019,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,639,622 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, MACQUARIE GROUP LTD, LOOMIS SAYLES & CO L P, Bank of New York Mellon Corp, RICE HALL JAMES & ASSOCIATES, LLC, GLENMEDE TRUST CO NA, and FULLER & THALER ASSET MANAGEMENT, INC..
This page lists
237
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.